Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma (Q33831073)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma |
scientific article |
Statements
1 reference
Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma (English)
1 reference
Joseph M Parker
1 reference
Chad K Oh
1 reference
Craig LaForce
1 reference
S David Miller
1 reference
David S Pearlman
1 reference
Chenxiong Le
1 reference
Gabriel J Robbie
1 reference
Wendy I White
1 reference
Barbara White
1 reference
Nestor A Molfino
1 reference
MEDI-528 Clinical Trials Group
1 reference
28 February 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference